MiR-222 in Cardiovascular Diseases: Physiology and Pathology
Joint Authors
Ding, Shengguang
Xu, Yiming
Zhong, Chongjun
Huang, Haitao
Zhu, Hao
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-01-03
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
MicroRNAs (miRNAs and miRs) are endogenous 19–22 nucleotide, small noncoding RNAs with highly conservative and tissue specific expression.
They can negatively modulate target gene expressions through decreasing transcription or posttranscriptional inducing mRNA decay.
Increasing evidence suggests that deregulated miRNAs play an important role in the genesis of cardiovascular diseases.
Additionally, circulating miRNAs can be biomarkers for cardiovascular diseases.
MiR-222 has been reported to play important roles in a variety of physiological and pathological processes in the heart.
Here we reviewed the recent studies about the roles of miR-222 in cardiovascular diseases.
MiR-222 may be a potential cardiovascular biomarker and a new therapeutic target in cardiovascular diseases.
American Psychological Association (APA)
Ding, Shengguang& Huang, Haitao& Xu, Yiming& Zhu, Hao& Zhong, Chongjun. 2017. MiR-222 in Cardiovascular Diseases: Physiology and Pathology. BioMed Research International،Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1137372
Modern Language Association (MLA)
Ding, Shengguang…[et al.]. MiR-222 in Cardiovascular Diseases: Physiology and Pathology. BioMed Research International No. 2017 (2017), pp.1-6.
https://search.emarefa.net/detail/BIM-1137372
American Medical Association (AMA)
Ding, Shengguang& Huang, Haitao& Xu, Yiming& Zhu, Hao& Zhong, Chongjun. MiR-222 in Cardiovascular Diseases: Physiology and Pathology. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1137372
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1137372
